Clinical Trial Update: Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148) [Phase 3]

View source ↗

Summary

A Phase 3 trial update for Vytorin (ezetimibe/simvastatin) in adults with hyperlipidemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hyperlipidemia | Phase 3 | Status: COMPLETED